Amedisys (AMED) Stock Statistics & Valuation Metrics

Amedisys has a market cap or net worth of $3.12B. The enterprise value is $3.29B.

Amedisys has 32,819,637 shares outstanding. The number of shares has decreased by -2.65% in one year.

Amedisys’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 2.48%.

The current PE Ratio of Amedisys is 68.71. Amedisys’s PEG ratio is -0.13.

In the last 12 months, Amedisys had revenue of 2.35B and earned 43.23M in profits. Earnings per share was 1.32.

In the last 12 months, operating cash flow was 224.52M and capital expenditures -5.28M, giving a free cash flow of 219.24M billion.

Amedisys pays an annual dividend of ―, resulting in a dividend yield of ―

Amedisys upcoming earnings date is Jul 23, 2025, TBA Not Confirmed.

Amedisys as a current ratio of 1.23, with Debt / Equity ratio of 37.75%

In the past 12 months, Amedisys has paid 48.05M in taxes.

Amedisys EV to EBITDA ratio is 42.58, with an EV/FCF ratio of 14.54.

Amedisys has $284.88M in cash and marketable securities with ― in debt, giving a net cash position of $167.98M billion.

Gross margin is 37.73%, with operating margin of 4.03%, and net profit margin of 1.84%.

The average price target for Amedisys is $100.75, which is 11.43% higher than the current price. The consensus rating is Hold